The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2013628
WO Application Number:
US2007067777
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07761581.3
WO Publication Number:
WO2007127977
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
30/04/2007
Grant date:
06/01/2016
EP Publication Date:
14/01/2009
WO Publication Date:
08/11/2007
Claims Translations Received Date:
Claims Translation B1 Received Date:
15/03/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
06/01/2016
EP B1 Publication Date:
06/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/04/2027
Lapsed By Expiration Date:
Revocation Date:
12/12/2022
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
06/01/2016
Name:
Momenta Pharmaceuticals, Inc.
Address:
675 West Kendall Street, Cambridge, MA 02142-1110, United States of America (US)